MedTrace Logo

Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19)

NCT04358029 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2024-08-05

No results posted yet for this study

Summary

The objective of the study is to estimate the frequency of cardiac arrhythmias and characterize the mode of death in patients with coronavirus disease (SARS-CoV-2; COVID-19). The study will also evaluate the long term cardiac outcomes in patients previously diagnosed with COVID-19.

This is a single-center, retrospective/ prospective registry enrolling all COVID-19 positive patients at Mount Sinai Hospital.

Cohort 1:

Retrospective chart review:

1. Patients who have been diagnosed with COVID-19 infection at Mount Sinai Hospital will be included.
2. A cohort of 1000 influenza patients will also be evaluated for purpose of comparison.

Cohort 2:

Prospective data collection of 100 patients who:

1. Were hospitalized for COVID-19 and who had an abnormal echocardiogram during hospitalization.
2. A matched cohort (for age, gender, troponin level, and days since hospital discharge) who did not have abnormalities on their echocardiograms (or who did not undergo echocardiogram) to ascertain that in this unusual disease, subjects did not develop echo abnormalities following hospital discharge.

Conditions

  • COVID 19 Cardiac
  • COVID 16 Arrhythmia
  • COVID 19 Death

Sponsors & Collaborators

  • Vivek Reddy

    lead OTHER

Principal Investigators

  • Vivek Reddy, MD · Icahn School of Medicine at Mount Sinai

  • Martin Goldman, MD · Icahn School of Medicine at Mount Sinai

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-09
Primary Completion
2023-04-01
Completion
2023-04-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04358029 on ClinicalTrials.gov